Earnings Call · Q4 FY2023·2024-02-15

Q4 23EPS +5.59%·Rev n/aQ3 23EPS -10.95%·Rev n/aQ2 23EPS -11.39%·Rev n/aQ1 23EPS -44.72%·Rev n/a⚠ consensus missing

Ultragenyx Pharmaceutical Inc. RARE

+4.6%1d on move date+3.2% vs SPY3d−0.9%5d−4.0%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RARE calls or request research access.

More RARE calls Browse calls Request research access